-
公开(公告)号:US08158828B2
公开(公告)日:2012-04-17
申请号:US11785251
申请日:2007-04-16
申请人: James T. Dalton , Christina Barrett , Yali He , Seoung-Soo Hong , Duane D. Miller , Michael L. Mohler , Ramesh Narayanan , Zhongzhi Wu
发明人: James T. Dalton , Christina Barrett , Yali He , Seoung-Soo Hong , Duane D. Miller , Michael L. Mohler , Ramesh Narayanan , Zhongzhi Wu
IPC分类号: C07C233/65 , A61K31/165
CPC分类号: A61K31/138 , A61K31/40 , A61K31/445 , A61K31/55 , C07D221/12
摘要: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
摘要翻译: 本发明涉及新型选择性雌激素受体调节剂(SERM)。 SERM化合物可用于预防和/或治疗各种疾病和病症,包括预防和治疗诸如前列腺和乳腺癌,骨质疏松症,激素相关疾病,潮热或血管舒缩症状,神经系统疾病, 心血管疾病和肥胖。
-
公开(公告)号:US08637706B2
公开(公告)日:2014-01-28
申请号:US13362242
申请日:2012-01-31
申请人: James T. Dalton , Christina Barrett , Duane D. Miller , Seoung-Soo Hong , Yali He , Michael L. Mohler , Ramesh Narayanan , Zhongzhi Wu
发明人: James T. Dalton , Christina Barrett , Duane D. Miller , Seoung-Soo Hong , Yali He , Michael L. Mohler , Ramesh Narayanan , Zhongzhi Wu
IPC分类号: C07C233/65 , A61K31/165
CPC分类号: A61K31/138 , A61K31/40 , A61K31/445 , A61K31/55 , C07C233/60 , C07C233/65 , C07C233/75 , C07C233/84 , C07C235/38 , C07C235/56 , C07C235/66 , C07C251/48 , C07C255/57 , C07C311/29 , C07C2601/14 , C07D221/12 , C07D265/34 , Y02A50/402 , Y02A50/411 , Y02A50/414 , Y02A50/423
摘要: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
摘要翻译: 本发明涉及新型选择性雌激素受体调节剂(SERM)。 SERM化合物可用于预防和/或治疗各种疾病和病症,包括预防和治疗诸如前列腺和乳腺癌,骨质疏松症,激素相关疾病,潮热或血管舒缩症状,神经系统疾病, 心血管疾病和肥胖。
-
公开(公告)号:US20090062341A1
公开(公告)日:2009-03-05
申请号:US11604884
申请日:2006-11-28
申请人: James T. Dalton , Christina Barrett , Yali He , Seoung-Soo Hong , Duane D. Miller , Michael L. Mohler , Ramesh Narayanan , Zhongzhi Wu
发明人: James T. Dalton , Christina Barrett , Yali He , Seoung-Soo Hong , Duane D. Miller , Michael L. Mohler , Ramesh Narayanan , Zhongzhi Wu
IPC分类号: A61K31/4545 , C07C233/64 , A61K31/166 , A61K31/445 , C07D401/02 , C07K14/72 , C07D211/60 , C07D213/81 , A61K31/44
CPC分类号: A61K31/138 , A61K31/40 , A61K31/445 , A61K31/55 , C07D221/12
摘要: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
摘要翻译: 本发明涉及新型选择性雌激素受体调节剂(SERM)。 SERM化合物可用于预防和/或治疗各种疾病和病症,包括预防和治疗诸如前列腺和乳腺癌,骨质疏松症,激素相关疾病,潮热或血管舒缩症状,神经系统疾病, 心血管疾病和肥胖。
-
公开(公告)号:US09078888B2
公开(公告)日:2015-07-14
申请号:US12010225
申请日:2008-01-22
申请人: James T. Dalton , Duane D. Miller , Michael L. Mohler , Seoung-Soo Hong , Zhongzhi Wu , Devesh Srivastava
发明人: James T. Dalton , Duane D. Miller , Michael L. Mohler , Seoung-Soo Hong , Zhongzhi Wu , Devesh Srivastava
IPC分类号: A61K31/47 , A61K31/472 , C07D217/22 , C07D217/24
CPC分类号: A61K31/472 , C07D217/22 , C07D217/24 , Y02A50/463
摘要: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalamic disorders, cardiovascular disease, and obesity.
-
公开(公告)号:US20090030036A1
公开(公告)日:2009-01-29
申请号:US12010225
申请日:2008-01-22
申请人: James T. Dalton , Duane D. Miller , Michael L. Mohler , Seoung-Soo Hong , Zhongzhi Wu , Devesh Srivastava
发明人: James T. Dalton , Duane D. Miller , Michael L. Mohler , Seoung-Soo Hong , Zhongzhi Wu , Devesh Srivastava
IPC分类号: A61K31/47 , C07D217/00 , A61P25/00 , A61P9/00
CPC分类号: A61K31/472 , C07D217/22 , C07D217/24 , Y02A50/463
摘要: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalamic disorders, cardiovascular disease, and obesity.
摘要翻译: 本发明涉及一类新的核受体结合剂(NRBAs)。 NRBAs适用于预防和/或治疗各种疾病和病症,包括预防和治疗前列腺癌和乳腺癌等癌症,骨质疏松症,激素相关疾病,炎性疾病,氧化应激相关疾病如帕金森病 和中风,神经障碍,眼科疾病,心血管疾病和肥胖。
-
公开(公告)号:US20070265296A1
公开(公告)日:2007-11-15
申请号:US11785251
申请日:2007-04-16
申请人: James Dalton , Christina Barrett , Yali He , Seoung-Soo Hong , Duane Miller , Michael Mohler , Ramesh Narayanan , Zhongzhi Wu
发明人: James Dalton , Christina Barrett , Yali He , Seoung-Soo Hong , Duane Miller , Michael Mohler , Ramesh Narayanan , Zhongzhi Wu
IPC分类号: A61K31/167 , A61K31/136 , A61K31/192 , A61K31/445 , A61P19/00 , A61P19/10 , A61P3/00 , A61P35/00 , A61P37/00 , A61P5/00 , C07C211/54 , C07C233/11 , C07C63/00 , C07D211/00 , C07D221/12
CPC分类号: A61K31/138 , A61K31/40 , A61K31/445 , A61K31/55 , C07D221/12
摘要: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
摘要翻译: 本发明涉及新型选择性雌激素受体调节剂(SERM)。 SERM化合物可用于预防和/或治疗各种疾病和病症,包括预防和治疗诸如前列腺和乳腺癌,骨质疏松症,激素相关疾病,潮热或血管舒缩症状,神经系统疾病, 心血管疾病和肥胖。
-
公开(公告)号:US20110263703A1
公开(公告)日:2011-10-27
申请号:US13153427
申请日:2011-06-05
申请人: James T. Dalton , David A. Dickason , Seoung-Soo Hong , Thomas G. Bird , Tai Ahn
发明人: James T. Dalton , David A. Dickason , Seoung-Soo Hong , Thomas G. Bird , Tai Ahn
IPC分类号: A61K31/277 , A61P5/00 , C07C255/51
CPC分类号: A61K31/277 , C07C253/30 , C07C255/60
摘要: The present invention relates to solid forms of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
摘要翻译: 本发明涉及(S)-N-(4-氰基-3-(三氟甲基)苯基)-3-(4-氰基苯氧基)-2-羟基-2-甲基丙酰胺的固体形式及其制备方法。
-
公开(公告)号:US08563606B2
公开(公告)日:2013-10-22
申请号:US13153427
申请日:2011-06-05
申请人: James T. Dalton , David A. Dickason , Seoung-Soo Hong , Thomas G. Bird , Tai Ahn
发明人: James T. Dalton , David A. Dickason , Seoung-Soo Hong , Thomas G. Bird , Tai Ahn
IPC分类号: A61K31/277 , A61P5/00 , C07C255/51
CPC分类号: A61K31/277 , C07C253/30 , C07C255/60
摘要: The present invention relates to solid forms of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
摘要翻译: 本发明涉及(S)-N-(4-氰基-3-(三氟甲基)苯基)-3-(4-氰基苯氧基)-2-羟基-2-甲基丙酰胺的固体形式及其制备方法。
-
公开(公告)号:US06919357B2
公开(公告)日:2005-07-19
申请号:US10215547
申请日:2002-08-09
申请人: Duane D. Miller , Seoung-Soo Hong
发明人: Duane D. Miller , Seoung-Soo Hong
IPC分类号: A61K31/4168 , A61K31/4178 , A61K31/427 , A61K31/4427 , A61P15/10 , A61P43/00 , C07D233/52 , C07D233/88
CPC分类号: A61K31/4168 , A61K31/4178 , A61K31/427 , A61K31/4427 , C07D233/52
摘要: Aspects of the present invention are directed towards compounds of Formula I for the treatment of human erectile disorders including erectile dysfunction in men. wherein: R1 is hydrogen, halo, hydroxy, nitro, cyano, phenyl, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, carboxy, amino, cyclohexyl, C1-C6 alkylamino, or (C1-C6 alkyl)2amino; R2 is hydrogen, halo, hydroxy, nitro, cyano, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, carboxy, amino, C1-C6 alkylamino, or (C1-C6 alkyl)2amino; R3 is a group of the formula R4 is hydrogen or C1-C6 alkyl; R5 is hydrogen, halo, hydroxy, nitro, cyano, phenyl, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, carboxy, amino, C1-C6 alkylamino, or (C1-C6 alkyl)2amino; and R6 is hydrogen, halo, hydroxy, nitro, cyano, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, carboxy, amino, C1-C6 alkylamino, or (C1-C6 alkyl)2amino; or pharmaceutically acceptable salts thereof.
摘要翻译: 本发明的方面涉及用于治疗男性勃起功能障碍的人类勃起障碍的式I化合物。 其中:R 1是氢,卤素,羟基,硝基,氰基,苯基,三氟甲基,C 1 -C 6烷基,C C 1 -C 6烷氧基,羧基,氨基,环己基,C 1 -C 6烷基氨基或(C 1个C 6 -C 6烷基)亚氨基; R 2是氢,卤素,羟基,硝基,氰基,三氟甲基,C 1 -C 6烷基,C 1〜 或C 1 -C 6烷氧基,羧基,氨基,C 1 -C 6烷基氨基或(C 1 -C 6) -C 6 -C 6烷基)亚氨基; R 3是式R 4的基团是氢或C 1 -C 6烷基; R 3是氢或C 1 -C 6烷基; R 5是氢,卤素,羟基,硝基,氰基,苯基,三氟甲基,C 1 -C 6烷基,C 1 C 1 -C 6烷氧基,羧基,氨基,C 1 -C 6烷基氨基或(C 1〜 C 1 -C 6烷基)亚氨基; 和R 6是氢,卤素,羟基,硝基,氰基,三氟甲基,C 1 -C 6烷基,C 1〜 C 1 -C 6烷氧基,羧基,氨基,C 1 -C 6烷基氨基或(C 1 -C 12) C 6 -C 6烷基)亚氨基; 或其药学上可接受的盐。
-
公开(公告)号:US07968603B2
公开(公告)日:2011-06-28
申请号:US12228100
申请日:2008-09-29
申请人: James T. Dalton , David A. Dickason , Seoung-Soo Hong , Thomas G. Bird , Tai Ahn
发明人: James T. Dalton , David A. Dickason , Seoung-Soo Hong , Thomas G. Bird , Tai Ahn
IPC分类号: A61K31/165 , A61P5/26 , C07C237/14
CPC分类号: A61K31/277 , C07C253/30 , C07C255/60
摘要: The present invention relates to solid forms of (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide and process for producing the same.
摘要翻译: 本发明涉及(S)-N-(4-氰基-3-(三氟甲基)苯基)-3-(4-氰基苯氧基)-2-羟基-2-甲基丙酰胺的固体形式及其制备方法。
-
-
-
-
-
-
-
-
-